Table 1.
Baseline demographic and clinical parameters of patients with alcoholic hepatitis (n=49)
| Characteristic | Median (25–75 IQR) or n (%) |
|---|---|
| Age (years) | 52 (47–56) |
| Male (n (%)) | 39 (80) |
| Alcohol intake (g/day) | 100 (80–160) |
| Corticosteroids (n (%)) | 25 (51) |
| Laboratory and hemodynamic parameters | |
| Haemoglobin (g/dL) | 11 (10–13) |
| Leucocyte count (×109/L) | 8.4 (6.3–12.5) |
| Platelet count (×109/L) | 113 (77–201) |
| AST (U/L) | 117 (67–157) |
| ALT (U/L) | 37 (25–60) |
| Serum Na (mmol/L) | 135 (132–139) |
| Serum albumin (g/dL) | 2.6 (2.3–3.2) |
| Serum creatinine (mg/dL) | 0.9 (0.60–1.1) |
| Serum bilirubin (mg/dL) | 6.7 (3.0–18.7) |
| International normalised ratio | 1.6 (1.4–1.8) |
| HVPG (mm Hg) | 19 (15–22) |
| Alcoholic hepatitis severity scores at admission | |
| MELD score | 19 (14–24) |
| ABIC score | 7.8 (6.7–8.6) |
| ABIC class (n (%)) | |
| A (<6.71) | 11 (23) |
| B (6.71–8.99) | 30 (61) |
| C (≥9) | 8 (16) |
| Clinical decompensations during hospitalisation | |
| AKI (n (%)) | 20 (41) |
| Infection (n (%)) | 21 (43) |
| Mortality at 90 days (n (%)) | 14 (29) |
ABIC, Age-Bilirubin-INR-Creatinine score; AKI, acute kidney injury; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HVPG, hepatic venous pressure gradient; MELD, Model for End-stage Liver Disease.